What is Galectin Therapeutics?

Galectin Therapeutics is working to improve the lives of patients with NASH cirrhosis, fibrosis, and cancer. Learn more about our NAVIGATE Phase 2b/3 study in NASH cirrhosis. Videos about the science behind Galectin Therapeutics, including interviews with Dr. Ben Carson, Dick Uihlein, and GALT management. Learn more

What is galectin pharmacology & drug development?

We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function...

How many research reports have been made about Galectin Therapeutics?

Galectin Therapeutics has only been the subject of 1 research reports in the past 90 days. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases.